Differential Treatment Response to Insulin Intensification Therapy: A Post Hoc Analysis of a Randomized Trial Comparing Premixed and Basal-Bolus Insulin Regimens

被引:4
作者
Shi, Li Xin [1 ]
Li, Peng Fei [2 ]
Hou, Jia Ning [2 ]
机构
[1] Guiyang Med Coll, Dept Endocrinol & Metab, Affiliated Hosp, Guiyang 550004, Guizhou, Peoples R China
[2] Lilly Suzhou Pharmaceut Co Ltd, Med Dept, Shanghai 200021, Peoples R China
关键词
Basal-bolus; Differential treatment response; Premixed insulin; SIDES algorithm; Type 2 diabetes mellitus; TYPE-2; DIABETIC-PATIENTS; ETHNIC-DIFFERENCES; PLASMA-GLUCOSE; A1C LEVELS; HYPERGLYCEMIA; SENSITIVITY; CARE; ASSOCIATION; MANAGEMENT; MORTALITY;
D O I
10.1007/s13300-017-0286-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Identification of subgroups of patients that may benefit most from certain treatment is important because individual treatment response varies due to multiple contributing factors. The present study used the subgroup identification based on the differential effect search (SIDES) algorithm to identify subgroups with different treatment responses to insulin intensification therapies. Methods: This was a post hoc analysis of a 24-week, multicenter, open-label, randomized, parallel study comparing prandial premixed therapy (PPT) to basal-bolus therapy (BBT). Patients with type 2 diabetes mellitus were randomized to PPT (insulin lispro mix 50/50 thrice daily with meals) or BBT (glargine at bedtime plus mealtime insulin lispro) insulin intensification therapies. The SIDES algorithm was used to identify the subgroups from at-goal patients [glycated hemoglobin (HbA1c) < 7.0% (53.0 mmol/mol) at the end of 24 weeks; n = 182] who could have benefitted from insulin intensification therapies. Results: Baseline characteristics of overall at-goal patients were comparable between PPT and BBT groups. The SIDES algorithm identified patients with race other than Caucasian (i.e., African-American, Asian, and Hispanic) and baseline fasting blood glucose (FBG) < 8.89 mmol/L as a subgroup that could respond better to PPT relative to BBT than the overall at-goal patient population. In this identified subgroup population, the HbA1c mean (standard deviation) changes from baseline to endpoint in PPT and BBT groups were -2.27 (0.88)% versus -2.05 (0.75)%; p = 0.40, respectively; while in the overall at-goal patients, the HbA1c changes were -2.17 (0.79)% versus -2.34 (1.00)%; p = 0.19, respectively. Conclusions: The preliminary results showed that the subgroup of patients with race other than Caucasian and FBG < 8.89 mmol/L may respond better to premixed intensification therapy. This result provides some preliminary information for further investigation in prospective studies.
引用
收藏
页码:915 / 928
页数:14
相关论文
共 39 条
[1]  
Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc11-S062, 10.2337/dc10-S011, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S011, 10.2337/dc12-s011, 10.2337/dc14-S081, 10.2337/dc13-S011]
[2]  
American Diabetes Association, 2017, Diabetes Care, V40, pS64
[3]  
[Anonymous], 1994, Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels
[4]  
[Anonymous], 2013, IDF DIABETES ATLAS
[5]   Patient adherence to medication requirements for therapy of type 2 diabetes [J].
Bailey, C. J. ;
Kodack, M. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (03) :314-322
[6]   A review of treatment response in type 2 diabetes: assessing the role of patient heterogeneity [J].
Cantrell, R. A. ;
Alatorre, C. I. ;
Davis, E. J. ;
Zarotsky, V. ;
Le Nestour, E. ;
Carter, G. Cuyun ;
Goetz, I. ;
Paczkowski, R. ;
Sierra-Johnson, J. .
DIABETES OBESITY & METABOLISM, 2010, 12 (10) :845-857
[7]  
Cerf Marlon E, 2013, Front Endocrinol (Lausanne), V4, P37, DOI 10.3389/fendo.2013.00037
[8]   IMPACT OF RACE/ETHNICITY ON THE EFFICACY AND SAFETY OF COMMONLY USED INSULIN REGIMENS: A POST HOC ANALYSIS OF CLINICAL TRIALS IN TYPE 2 DIABETES MELLITUS [J].
Davidson, Jaime A. ;
Lacaya, Lyndon B. ;
Jiang, Honghua ;
Heilmann, Cory R. ;
Scism-Bacon, Jamie L. ;
Gates, Jeffrey R. ;
Jackson, Jeffrey A. .
ENDOCRINE PRACTICE, 2010, 16 (05) :818-828
[9]   PREMIXED INSULIN PREPARATIONS IN PEN SYRINGES MAINTAIN GLYCEMIC CONTROL AND ARE PREFERRED BY PATIENTS [J].
DUNBAR, JM ;
MADDEN, PM ;
GLEESON, DT ;
FIAD, TM ;
MCKENNA, TJ .
DIABETES CARE, 1994, 17 (08) :874-878
[10]   Premixed insulin analogues for the treatment of diabetes mellitus [J].
Garber, AJ .
DRUGS, 2006, 66 (01) :31-49